Archford Capital Strategies’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-69
| Closed | -$2K | – | 577 |
|
2017
Q1 | $2K | Hold |
69
| – | – | ﹤0.01% | 612 |
|
2016
Q4 | $2K | Buy |
69
+7
| +11% | +$203 | ﹤0.01% | 537 |
|
2016
Q3 | $2K | Sell |
62
-62
| -50% | -$2K | ﹤0.01% | 552 |
|
2016
Q2 | $6K | Buy |
+124
| New | +$6K | ﹤0.01% | 467 |
|
2016
Q1 | – | Sell |
-619
| Closed | -$42K | – | 551 |
|
2015
Q4 | $42K | Buy |
619
+66
| +12% | +$4.48K | 0.02% | 277 |
|
2015
Q3 | $32K | Sell |
553
-56
| -9% | -$3.24K | 0.02% | 222 |
|
2015
Q2 | $36K | Buy |
609
+148
| +32% | +$8.75K | 0.03% | 219 |
|
2015
Q1 | $28.7K | Hold |
461
| – | – | 0.02% | 252 |
|
2014
Q4 | $27K | Buy |
461
+398
| +632% | +$23.3K | 0.02% | 262 |
|
2014
Q3 | $3K | Hold |
63
| – | – | ﹤0.01% | 461 |
|
2014
Q2 | $3.3K | Buy |
63
+10
| +19% | +$524 | ﹤0.01% | 567 |
|
2014
Q1 | $2.8K | Buy |
+53
| New | +$2.8K | ﹤0.01% | 600 |
|